logo
Select company
Select metric
-73.16%EBIT Margin
VS
Market
14
Sector
42
Industry
29
History
88
$ 5.02Close
$ 3.57 - $ 5.77 52-Week Range
Ticker Information

Ticker

TLSI

Company Name

TRISALUS LIFE SCIENCES INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

TRISALUS LIFE SCIENCES INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TLSI - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -26.33M-73.16%$ 35.99M
3/31/2025$ -22.91M-71.28%$ 32.14M
12/31/2024$ -26.95M-91.57%$ 29.43M
9/30/2024$ -53.43M-198.68%$ 26.89M
6/30/2024$ -53.45M-216.08%$ 24.73M
3/31/2024$ -63.96M-290.94%$ 21.98M
12/31/2023$ -59.01M-318.8%$ 18.51M
9/30/2023$ -76.79M-304.86%$ 25.19M
6/30/2023$ -74.65M-373.38%$ 19.99M
3/31/2023$ 2.85M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TRISALUS LIFE SCIENCES INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, TRISALUS LIFE SCIENCES INC's average EBIT % has been -215.42%.
  • The median EBIT % for TRISALUS LIFE SCIENCES INC during this period was -216.08%
  • TRISALUS LIFE SCIENCES INC reached its highest EBIT % over the past 5 years at -71.28%.
  • The lowest EBIT % recorded by TRISALUS LIFE SCIENCES INC in the same timeframe -373.38%

TRISALUS LIFE SCIENCES INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
MXCT : MAXCYTE INC -125.22%RPID : RAPID MICRO BIOSYSTEMS INC -152.69%CVRX : CVRX INC -85.77%CCCC : C4 THERAPEUTICS INC -325.5%UTMD : UTAH MEDICAL PRODUCTS INC 39.89%SNWV : SANUWAVE HEALTH INC -71.39%CLPT : CLEARPOINT NEURO INC -65.79%CTSO : CYTOSORBENTS CORP -26.29%SRTS : SENSUS HEALTHCARE INC -1.31%MYO : MYOMO INC -21.76%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for TRISALUS LIFE SCIENCES INC is calculated as follows: EBIT [ $ -105.19K ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

TLSI - EBIT Margin, Last 5 years

-373.38%

Minimum

Jun 30, 2023

-71.28%

Maximum

Mar 31, 2025

-215.42%

Average

-216.08%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%